CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis

BACKGROUND: Resistance to chemotherapy is a major obstacle to curing acute myeloid leukaemia (AML), and several antigens are claimed to play primary roles in this resistance. PURPOSE: The aim of this study was to evaluate the roles of CD56, CD11b and Smac/DIABLO gene expression levels as prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Abeer, Zahran, Asmaa M, Aly, Sanaa Shaker, Refaat, Ahmed, Hassan, Mohammed H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318388/
https://www.ncbi.nlm.nih.gov/pubmed/30486609
http://dx.doi.org/10.31557/APJCP.2018.19.11.3187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318388/
https://www.ncbi.nlm.nih.gov/pubmed/30486609
http://dx.doi.org/10.31557/APJCP.2018.19.11.3187

Ejemplares similares